ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Smith and Nephew Plc New

Smith and Nephew Plc New (SNN)

24.66
-0.13
(-0.52%)
Cerrado 22 Diciembre 3:00PM
24.655
-0.005
(-0.02%)
Fuera de horario: 6:59PM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
24.66
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
2,985,631
24.585 Rango del Día 24.85
23.65 Rango de 52 semanas 31.72
Capitalización de Mercado [m]
Precio Anterior
24.79
Precio de Apertura
24.75
Última hora de negociación
Volumen financiero
US$ 73,858,940
Precio Promedio Ponderado
24.7381
Volumen promedio (3 m)
776,375
Acciones en circulación
437,187,056
Rendimiento del Dividendo
3.04%
Ratio Precio/Utilidad
16.20
Beneficio por acción (BPA)
0.6
turnover
5.55B
Beneficio neto
263M

Acerca de Smith and Nephew Plc New

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from... Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder. Mostrar más

Sector
Ortho,prosth,surg Appl,suply
Industria
Ortho,prosth,surg Appl,suply
Sede
Watford, Gbr
Fundado
1937
Smith and Nephew Plc New is listed in the Ortho,prosth,surg Appl,suply sector of the New York Stock Exchange with ticker SNN. The last closing price for Smith and Nephew was US$24.79. Over the last year, Smith and Nephew shares have traded in a share price range of US$ 23.65 to US$ 31.72.

Smith and Nephew currently has 437,187,056 shares in issue. The market capitalisation of Smith and Nephew is US$10.84 billion. Smith and Nephew has a price to earnings ratio (PE ratio) of 16.20.

SNN Últimas noticias

Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty

Latest expansion to the CORI◊ Surgical System portfolio provides a personalized solution for patients and surgeons Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today...

Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food & Drug Administration for a stemless...

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for...

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery

Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a...

Smith+Nephew raises the bar in knee revisions by launching new LEGION™ Hinged Knee System with OXINIUM™ Technology

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) System is now available in the United States with proprietary OXINIUM...

First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces promising surgeon feedback from the first completed cases utilizing its new CATALYSTEM Primary Hip System...

3D Systems Expands Orthopedic Surgical Planning Portfolio Receiving FDA Clearance for Key Ankle Indications

New TOTAL ANKLE Patient-Matched Guides pair with Smith+Nephew’s Total Ankle replacement solution, designed to help surgeons save time and ensure accuracy while performing fewer steps than standard...

Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its TOTAL ANKLE Patient-Matched Guides, giving surgeons a predictable and efficient option to...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.96-3.7470725995325.6225.724.65551737225.16693779DR
4-0.56-2.2204599524225.2225.9824.65561422625.43651165DR
12-6.25-20.219993529630.9131.35523.8577637526.59815884DR
26-0.55-2.1816739389125.2131.7223.8575843127.81534188DR
52-2.23-8.2930457419126.8931.7223.6583914426.97979475DR
156-7.61-23.582274558432.2736.6821.52592868027.46331313DR
260-23.3-48.582151793247.9652.2621.52578013030.99830346DR

SNN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Smith and Nephew?
El precio actual de las acciones de Smith and Nephew es US$ 24.66
¿Cuántas acciones de Smith and Nephew están en circulación?
Smith and Nephew tiene 437,187,056 acciones en circulación
¿Cuál es la capitalización de mercado de Smith and Nephew?
La capitalización de mercado de Smith and Nephew es USD 10.84B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Smith and Nephew?
Smith and Nephew ha negociado en un rango de US$ 23.65 a US$ 31.72 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Smith and Nephew?
El ratio precio/beneficio de Smith and Nephew es 16.2
¿Cuál es el ratio de efectivo a ventas de Smith and Nephew?
El ratio de efectivo a ventas de Smith and Nephew es 0.77
¿Cuál es la moneda de reporte de Smith and Nephew?
Smith and Nephew presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Smith and Nephew?
El último ingresos anual de Smith and Nephew es USD 5.55B
¿Cuál es el último beneficio anual de Smith and Nephew?
El último beneficio anual de Smith and Nephew es USD 263M
¿Cuál es la dirección registrada de Smith and Nephew?
La dirección registrada de Smith and Nephew es BUILDING 5, CROXLEY PARK, HATTERS LANE, HERTFORDSHIRE, WATFORD, WD18 8YE
¿En qué sector industrial opera Smith and Nephew?
Smith and Nephew opera en el sector ORTHO,PROSTH,SURG APPL,SUPLY

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
VNCEVince Holding Corp
US$ 4.70
(69.06%)
1.06M
SRFMSurf Air Mobility Inc
US$ 3.33
(23.79%)
376.77k
BBBlackBerry Limited
US$ 3.685
(23.66%)
40.8M
ALURAllurion Technologies Inc
US$ 0.3439
(22.87%)
744.34k
CLWClearWater Paper Corporation
US$ 30.26
(22.46%)
3.5M
IIPRInnovative Industrial Properties Inc
US$ 73.50
(-22.91%)
3.15M
KUKEKuke Music Holding Limited
US$ 0.31
(-20.51%)
61.48k
NVONovo Nordisk
US$ 85.00
(-17.83%)
53.81M
CANGCango Inc
US$ 5.08
(-11.81%)
2.44M
BNEDBarnes and Noble Education Inc
US$ 9.965
(-10.31%)
1.55M
QBTSD Wave Quantum Inc
US$ 6.638
(4.21%)
124.42M
PFEPfizer Inc
US$ 26.36
(2.29%)
116.33M
APOApollo Global Management Inc
US$ 171.03
(0.83%)
94.52M
TAT&T Inc
US$ 22.75
(0.80%)
93.94M
FFord Motor Company
US$ 9.885
(1.49%)
87.66M

SNN Discussion

Ver más
ValueInvestor15 ValueInvestor15 8 años hace
Morgan Stanley upgraded SNN today. Analysis supports rating change:

Analysis
👍️0
bshep bshep 9 años hace
http://www.ft.com/intl/cms/s/0/24d16020-6083-11e5-a28b-50226830d644.html?ftcamp=published_links%2Frss%2Fmarkets%2Ffeed%2F%2Fproduct#axzz3mUlZfHgr
👍️0
Sundance2 Sundance2 10 años hace
Well..Well...Well. Looks like I was right to drop out after ER when it was in the $36 range. Not sure why the drop and high vol. but none the less will watch to see it drops further.
👍️0
Sundance2 Sundance2 10 años hace
Just as I expected, little bounce on ER yesterday and she starts heading back down today. Will wait for afternoon bounce and sell.

Just not enough gain to make it worth holding. Other stocks have better potential.

👍️0
Sundance2 Sundance2 10 años hace
Ok, I'm close to dumping the stock. Talk about a dog the last two months... I'll hold through earnings to see if I can get a little bump and then move fund to other stocks. This one is simply dead money.

Only chance I see of it going up is if buy out happens but that has been in the rumor mill for years now. I'm not sure anyone is all that interested or it would have already been bought.

I have to admit I'm not really all that confident that the ER will be that great.
👍️0
Sundance2 Sundance2 10 años hace
Well, I guess there isn't any news since no one has replied or posted anything on this board for 2 weeks.

I did check the calls and puts for next month and there is a lot of calls for 40 and 45 and virtually nothing for puts.

So a lot of traders seem to expect a lot higher price this coming month. Hmmmmm... The lower of the two would be a huge gain for me....
👍️0
Sundance2 Sundance2 10 años hace
Anyone out there hear anymore about buyout from SYK.
Bloomberg reported bid from SYK within weeks just before new year day.
👍️0
OGSPECULATOR OGSPECULATOR 11 años hace
Load and hold$$$
👍️0
reaper247 reaper247 13 años hace
Thanks, Dan. EOM.
👍️0
reaper247 reaper247 13 años hace
Smith-Nephew potential bounce coming. If not, hold long term for divies.

Scores 4 out of 5 stars on dividendinvestor.com

http://www.dividendinvestor.com/?chk=2d1f51312939092&symbol=snn&submit=GO

IMO and FWIW.
👍️0
texas4qld texas4qld 21 años hace
Hi backlash, I hold 517173 shares at an average of approx 16c.
I first got into MXS when they trading at around 3c. Soon after they were consolidated 1:5.

I cant find any info on CAE and I guess one day it'll be hard to find info about MXS

I think 2004 will be a good year for SNN and the overall market.
I'm also holding WOW AvV & SSR.

All the best................Tex.
👍️0
backlash backlash 21 años hace
> Looking forward to my Div Chq of $7757.62. !!

damn you must have a fair few shares ;) (too lazy to calc).

i bought in when this was still called Capital energy. Topped up just before it went into suspension at around the $0.40/0.50 mark. came outta suspension and watched it fall.

no idea how many shares i have in it anymore! it's been that long.

does anyone know if there was a consolidation of shares (10 to 1) when it was CAE/MXS? i seem to recall that there was.
👍️0
texas4qld texas4qld 21 años hace
http://www.sonnet.com.au/Archive/Vantage%20Sonnet%20Report%20Nov%202003.pdf
👍️0
texas4qld texas4qld 21 años hace
Just to give you an idea of what the AOT finacial display is at the moment: notice the group description has changed from "Telecommunication Services" to "Software & Services" plus yield now looks better at 7.5% instead of zero !! Also note that the PE is still way out because it's based on last years earnings.

------------------------------------
SNN Sonnet Corporation (formerly MXS)10-10-03
Shares on Issue 360,391,387
Price (previous close in cents) 4.5
Market Cap ($) 16,217,612
Earnings (cents per share) 0.26
Price To Earnings 17.31
Dividends (cents per share) 0
Yield (%) 0.00
Asset Backing (cents per share) 1
Price to Assets 4.50
---------------------

SNN Sonnet Corporation 28-11-03
Industry Group Telecommunication Services
Shares on Issue 75,079,547
Price (previous close in cents) 17
Market Cap ($) 12,763,523
Earnings (cents per share) 0.26
Price To Earnings 65.38
Dividends (cents per share) 0 Yield (%) 0.00
Asset Backing (cents per share) 1
Price to Assets 17.00
--------------------------------------
SNN Sonnet Corportion Industry Group Software & Services 4-12-03
Shares on Issue 75,079,547
Price (previous close in cents) 20
Market Cap ($) 15,015,909
Last Annual Report Data and Ratios Earnings (cents per share) 0.26
Price To Earnings 76.92
Dividends (cents per share) 1.5
Yield (%) 7.50
Asset Backing (cents per share) 1
Price to Assets 20.00
----------------------------------------

Once these accounts are adjusted to reflect current revenues and nett profits the stock will attract new stock screeners.
Any other positive news between now and then (new contracts etc)will also be a positive driver of the price.

Looking forward to my Div Chq of $7757.62. !!

Cheers Tex.

👍️0
rangi rangi 21 años hace
been alot of selling of good stcoks to get into the small cap miners, come the new year this could change, as we found with cfr , they go up quick and come down quick.So I fell you just keep buying at thes elevels and wait .
👍️0
texas4qld texas4qld 21 años hace
I think SNN has got plenty of upside over the next 4 months.

SNN Previously Maxis Corporation was relisted on ASX: August 2001 with issue of ordinary shares of 100,000,000 at 2c. currently there are 75 million shares in the company at 19c after 1:5 consolidation.

http://www.sonnet.com.au/

------------------------------------
The stock is held between three core groups in roughly equal 20 pct stakes – one group is a handful of high net worth individuals who took place in the recapitalisation in August 2002, , another is Marcel Dufour and family members and the third is John Beville, a Sydney based property developer in BRW’s Rich List and a canny investor in micro caps (took an early stake in Tribeca).
The new Executive team took over in December 2002 and has been in a turnaround reconstruction process since. The company expects to begin talking to brokers to seek to broaden its footprint in the marketplace around February next year.
---------------------------------------------------------

employees: 77 (tripled since 2002)
Revenues:$20.2 million ($9.5 million 2002) $28 million projected for 2004.
Cash in bank: $3.7 million (up from $1.3 million)
Profit:2003 $890,227 (2002-loss $2.9 million. 2003-loss $78 Million)

Sale of Loss making business: "ARBT" sold for $50k (book gain $600k), arbt lost $1.2 million in last 9 months alone.

New business purchase: "Senteq" $1.06 million

Economic dependency (similar to LOK and microsoft)has been reduced: A new 3 year contract has been secured with "cisco systems" on 17th of January 2003.
The purchase of "Senteq" is designed to deversify sonnets revenue base and dependency.

Share details: a consolidation of 1:5 has recently taken place creating a total of 75 million shares.

Outstanding options: 1.2 million

Controlled companys 100% owned:
(1) Capital Gas fields
(2) Hancock holdings
(3) Pulsar Graphite
(4) Rescan NL 80%
(5) ABT supplyline
(6) NDT
(7) Senteq information systems

-----------------------------------------

http://brw.com.au/stories/19990528/2306.htm

John Beville (one of Australias richest men) originally held 1.76% of MXS (now SNN) He is now holds 18.5% of SNN

He was personally worth $130 million back in 1999.

----------------------------------------
MAXIS PROFILE

Maxis was incorporated in Western Australia in 1987 as Glacial Exploration NL, they changed to Quicksilver Resources NL in 1989 and Capital Energy NL in 1994, the same year it was listed on the ASX initially as a diamond explorer and diversified into oil and gas production in 1993 and gas exploration in 1994 and 1995.
The Company changed it's name to Maxis Corporation in January 2000.
They purchased 4 other companys in July 2000 two of which went into voluntary administration in 2001, resulting in the suspension of MXS for 18 months.
They have now completed the restructure (October 30 2003) and have no debt with strong cash flow.


RECENT FIGURES FROM SONNET.

On October 14 Sonnet announced EBITDA for the nine months to Sep 30 2003 had reached $2.63 million, well on track to meet the forecast provided in July for a calendar year EBITDA range between $2.5/3.5 million.
-----------------------------------
THE BUSINESS

1/ Managed Networks:
Managed Networks, the existing business, provides System Integration Services, design and implementation and project management.
Its Managed Services team provides remote monitoring, remote management and reporting services.
In January this year Maxis Corporation announced CSC renewed its major contract with the company's subsidiary Managed Networks. This extension will be for a further three years and the financial terms will be substantially the same as those applying in prior years. As this contract was the primary income source for the group, the board sees this renewal as providing a sound footing for business for the coming calendar year (although the new contract includes a clause that allows the client to terminate at any time with three months notice).
Maxis has a sub contract from service supplier CSC that provides and manages the services for a NSW Government Department.
Maxis built and now operates a NSW Government Department’s wide area network (WAN).
---------------------------------------

Tex.








👍️0
HabaneroDog HabaneroDog 21 años hace
Yea sorry tex I just can't seem to leave a perfectly good grub sittin around......HARR!
👍️0
HabaneroDog HabaneroDog 21 años hace
Howdy.....Buy a membership and come on over and visit us on Salt Spray.....
http://www.investorshub.com/boards/board.asp?board_id=2037
👍️0
texas4qld texas4qld 21 años hace
spammer !!! eom.


👍️0
texas4qld texas4qld 21 años hace
Hi guys

I've started this forum because Pat is too slack to pull his finger out and update ozestocks and hotcopper.
This would be a good spot to post any current info on Sonnet Corporation (formerley Maxis corporation).

Cheers Tex.

👍️0
HabaneroDog HabaneroDog 21 años hace
"GRUB"
👍️0

Su Consulta Reciente

Delayed Upgrade Clock